U. Cassens et al., KINETICS OF CD34-GSF-MOBILIZED PATIENTS AND RELATED DONORS( CELLS IN BLOOD AND LEUKAPHERESIS PRODUCTS OF G), Infusionstherapie und Transfusionsmedizin, 22, 1995, pp. 125-128
Background: Since there is little conclusive data about the apheresis-
induced kinetics and changes of CD34+ cells, we analyzed the relation
of CD34+ cells in blood before and after leukapheresis to the yields i
n apheresis products. Methods: We investigated the amount of CD34+ cel
ls in a total of 51 peripheral blood progenitor cell (PBPC) apheresis
products and in peripheral blood before and after PBPC apheresis of 20
patients/related donors. Progenitor cells were mobilized with 2x12 mu
g G-CSF/kg body weight for patients, whereas related donors obtained
2 x 5 mu g G-CSF/kg body weight (bw). Results: Flow cytometric analysi
s showed decreasing CD34+ cells in blood and apheresis products for co
nsecutive PBPC aphereses for both groups. Similar decrease rates of CD
34+ cells in blood during PBPC apheresis procedures for patients (mean
decrease 34.8%) and related donors (mean decrease 34.3%) demonstrate
comparable kinetics. Regression analysis showed a correlation coeffici
ent of r=0.75 for CD34+ cells in blood and apheresis products, and r=0
.24 for WBC in blood and CD34+ cells in leukapheresis products. Conclu
sion: The results confirm the feasibility and efficiency of CD34+ cell
monitoring in blood predicting the yields of PBPC aphereses. Kinetics
of CD34+ cells show a maximum after 5 days administration of G-CSF (f
irst apheresis) with consecutive decreases of CD34+ cells in both bloo
d and apheresis products for patients and related donors.